Commentary

Treating patients during COVID-19: What I observed


 

6. Support, especially from family but also institutional support, trumped other factors. The more support and structure our patients had, the better they did.

My observations may not be generalizable because I am reporting on a relatively small population size, most patients were older, and most were established patients who were likely more stable. I plan to follow up with these patients to see how the new COVID-19 world continues to affect them, and us.

Daniel D. Storch, MD
Key Point Health Services
Catonsville, Maryland

Disclosure: The author reports no financial relationships with any companies whose products are mentioned in this article, or with manufacturers of competing products.

Pages

Recommended Reading

FDA clears first brain stimulation device to help smokers quit
MDedge Psychiatry
Adolescent e-cigarette use: A public health crisis
MDedge Psychiatry
Fecal transplant shows promise in reducing alcohol craving
MDedge Psychiatry
High schoolers prefer tobacco as vapor, not smoke
MDedge Psychiatry
Reworked OxyContin fails to cut overall opioid abuse, FDA panel says
MDedge Psychiatry
New acute pain guidelines from the ACP and AAFP have limitations
MDedge Psychiatry
Is psychiatry coddling the American mind?
MDedge Psychiatry
What to do when a patient is not ready to stop smoking
MDedge Psychiatry
Cannabis-derived compounds: What you need to know
MDedge Psychiatry
COVID-19 shutdown fuels sharp rise in alcohol use
MDedge Psychiatry